PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Other financing activities (2023 - 2026)

PepGen (PEPG) posted Other financing activities of $7000.0 for Q1 2026, up 100.01% sequentially from -$107.8 million in Q4 2025.

Analysis

PepGen (PEPG) Other financing activities (2023 - 2026) Analysis & Trends

PepGen has reported Other financing activities for 4 years, with the latest figure at $7000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299000.0 (changed N/A YoY) and the FY2025 annual result came in at $292000.0, down 99.62% from the prior year.
  • Other financing activities climbed to $7000.0 in Q1 2026 per PEPG's latest filing, from -$107.8 million in the prior quarter.
  • Over five years, Other financing activities peaked at $108.1 million in Q3 2025 and troughed at -$107.8 million in Q4 2025.
  • A 4-year average of $11.1 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
  • The widest YoY moves for Other financing activities: up 59036.92% in 2024, down 59036.92% in 2024.
  • Over 4 years, Other financing activities stood at $38000.0 in 2023, then surged by 202210.53% to $76.9 million in 2024, then plunged by 240.23% to -$107.8 million in 2025, then soared by 100.01% to $7000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $7000.0, -$107.8 million, and $108.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 PepGen 217.99 Mn 217.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 110,000.00
Mar 31, 2026 7,000.00
Sep 30, 2025 108.00 Mn
Jun 30, 2025 98,000.00
Mar 31, 2024 76.88 Mn
Dec 31, 2023 38,000.00
Jun 30, 2023 85,000.00
Mar 31, 2023 130,000.00